IAD Index of Academic Documents
  • Home Page
  • About
    • About Izmir Academy Association
    • About IAD Index
    • IAD Team
    • IAD Logos and Links
    • Policies
    • Contact
  • Submit A Journal
  • Submit A Conference
  • Submit Paper/Book
    • Submit a Preprint
    • Submit a Book
  • Contact
  • Kocatepe Tıp Dergisi
  • Volume:26 Issue:1
  • A CASE OF CHICKENPOX INFECTION FOLLOWING COVID-19 VACCINATION

A CASE OF CHICKENPOX INFECTION FOLLOWING COVID-19 VACCINATION

Authors : İrem Nur Durusu, Gulhan Gurel
Pages : 76-79
Doi:10.18229/kocatepetip.1132844
View : 42 | Download : 35
Publication Date : 2025-01-27
Article Type : Other Papers
Abstract :We are in the middle of Coronavirus disease 2019 (COVID-19) pandemic and to take control the disease burden several COVID-19 vaccines have been authorized and approved for distribution worldwide. Pfizer-BioNTech vaccine which is a nucleoside-modified RNA vaccine (BNT162b2 Comirnatry) is one of the most important and effective COVID-19 vaccines. As the number of vaccinated people increases, we see various cutaneous side effects related to vaccination. Delayed local reactions, morbilliform rashes, urticaria are among the most common side effects. Herein, a 38-year-old immunocompetent patient with second time experienced chickenpox infection developed immediately after the second dose of Pfizer-BioNTech vaccine is presented. With this case, we reviewed the fact that chickenpox disease is not supply a life-long immunity in all people, it can be re-triggered by some immune mechanisms related with vaccination.
Keywords : Suçiçeği, SARS-CoV-2, COVID-19 Aşıları

ORIGINAL ARTICLE URL

* There may have been changes in the journal, article,conference, book, preprint etc. informations. Therefore, it would be appropriate to follow the information on the official page of the source. The information here is shared for informational purposes. IAD is not responsible for incorrect or missing information.


Index of Academic Documents
İzmir Academy Association
CopyRight © 2023-2026